The pathophysiology of anemia in CKD is multifaceted and complex but mainly involves the development of erythropoietin deficiency and resistance as well as a heightened inflammatory state
doi: 10.2337/dc08-1309 Summary Keywords glucagon-like peptide-1 receptor agonist, acute kidney injury, adverse event reporting system, data mining, onset time, outcome Citation Dong S and Sun C (2022) Can glucagon-like peptide-1 receptor agonists cause acute kidney injury
Benzyl alcohol, while a robust preservative, is not invincible
Zepbound, Semaglutide GLP-1, and Wegovy are all medications used for weight loss, but they work in slightly different ways
Tan et al., reported that FIIN-2, an irreversible covalent FGFR inhibitor, formed the covalent binding mode at the Cys477 residue of FGFR4 in the DGF-out conformation (96)